These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30192439)

  • 21. Trisubstituted barbiturates and thiobarbiturates: Synthesis and biological evaluation as xanthine oxidase inhibitors, antioxidants, antibacterial and anti-proliferative agents.
    Figueiredo J; Serrano JL; Cavalheiro E; Keurulainen L; Yli-Kauhaluoma J; Moreira VM; Ferreira S; Domingues FC; Silvestre S; Almeida P
    Eur J Med Chem; 2018 Jan; 143():829-842. PubMed ID: 29223098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel 3-substituted N-methylcarbazole-imidazolium salt derivatives: Synthesis and cytotoxic activity.
    Li YH; Zhou B; Shi YM; Xun YP; Yang YH; Yang LJ
    Chem Biol Drug Des; 2018 Jul; 92(1):1206-1213. PubMed ID: 29430875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antiproliferative activity of ammonium and imidazolium ionic liquids against T98G brain cancer cells.
    Kaushik NK; Attri P; Kaushik N; Choi EH
    Molecules; 2012 Nov; 17(12):13727-39. PubMed ID: 23174892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold.
    Baqi Y; Lee SY; Iqbal J; Ripphausen P; Lehr A; Scheiff AB; Zimmermann H; Bajorath J; Müller CE
    J Med Chem; 2010 Mar; 53(5):2076-86. PubMed ID: 20146483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lead optimization and biological evaluation of fragment-based cN-II inhibitors.
    Guillon R; Rahimova R; Preeti ; Egron D; Rouanet S; Dumontet C; Aghajari N; Jordheim LP; Chaloin L; Peyrottes S
    Eur J Med Chem; 2019 Apr; 168():28-44. PubMed ID: 30798051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, Synthesis and Antiproliferative Activities of Oxidative Stress Inducers Based on 2-Styryl-3,5-dihydro-4H-imidazol-4-one Scaffold.
    Omar AM; Abdelghany TM; Abdel-Bakky MS; Alahdal AM; Radwan MF; El-Araby ME
    Chem Pharm Bull (Tokyo); 2018 Oct; 66(10):967-975. PubMed ID: 30047515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
    Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA
    Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD73 inhibition by purine cytotoxic nucleoside analogue-based diphosphonates.
    Dumontet C; Peyrottes S; Rabeson C; Cros-Perrial E; Géant PY; Chaloin L; Jordheim LP
    Eur J Med Chem; 2018 Sep; 157():1051-1055. PubMed ID: 30176535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibacterial activities of mono-, di- and tri-substituted triphenylamine-based phosphonium ionic liquids.
    Brunel F; Lautard C; di Giorgio C; Garzino F; Raimundo JM; Bolla JM; Camplo M
    Bioorg Med Chem Lett; 2018 Mar; 28(5):926-929. PubMed ID: 29439903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study on the potential anti-cancer activity of phosphonium and ammonium-based ionic liquids.
    Kumar V; Malhotra SV
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4643-6. PubMed ID: 19615902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Ionic Liquids and Ionic Liquids Active Pharmaceutical Ingredients Inhibition in Elastase Enzyme Activity.
    Mota FAR; Pereira SAP; Araujo ARTS; Saraiva MLMFS
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33401768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and structure--activity relationship of new cytotoxic agents targeting human glutathione-S-transferases.
    Rotili D; De Luca A; Tarantino D; Pezzola S; Forgione M; Morozzo Della Rocca B; Falconi M; Mai A; Caccuri AM
    Eur J Med Chem; 2015 Jan; 89():156-71. PubMed ID: 25462236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and in vitro antiproliferative activity of new 1,3-(oxytetraethylenoxy)-cyclotriphosphazene derivatives.
    Siwy M; Sek D; Kaczmarczyk B; Wietrzyk J; Nasulewicz A; Opolski A
    Anticancer Res; 2007; 27(3B):1553-8. PubMed ID: 17595775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safe and selective anticancer agents from tetrafluorinated azobenzene-imidazolium ionic liquids: Synthesis, characterization, and cytotoxic effects.
    Babamale HF; Khor BK; Chear NJ; Yam WS
    Arch Pharm (Weinheim); 2022 Aug; 355(8):e2200085. PubMed ID: 35478416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2-Substituted-1-(2-morpholinoethyl)-1H-naphtho[2,3-d]imidazole-4,9-diones: Design, synthesis and antiproliferative activity.
    Liu Z; Zhang Z; Zhang W; Yan D
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2454-2458. PubMed ID: 29884536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of phenyl alkyl imidazole-based compounds as potent inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).
    Owen CP; Shahid I; Olusanjo MS; Patel CH; Dhanani S; Ahmed S
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):117-27. PubMed ID: 18620055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indium-Mediated Allylation of Carbonyl Compounds in Ionic Liquids: Effect of Salts in Ionic Liquids.
    Hirashita T; Takahashi F; Noda T; Takagi Y; Araki S
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29997380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Alkylimidazolium Ionic Liquids as an Antibacterial Alternative to Pathogens of the Skin and Soft Tissue Infections.
    Forero Doria O; Castro R; Gutierrez M; Gonzalez Valenzuela D; Santos L; Ramirez D; Guzman L
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30223457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imidazolium ionic liquids containing selenium: synthesis and antimicrobial activity.
    Alberto EE; Rossato LL; Alves SH; Alves D; Braga AL
    Org Biomol Chem; 2011 Feb; 9(4):1001-3. PubMed ID: 21157603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-Substituted-2-butyl-5-chloro-3H-imidazole-4-carbaldehyde derivatives as anti-tumor agents against Ehrlich ascites tumor cells in vivo.
    Kumar CA; Swamy SN; Gaonkar SL; Basappa ; Salimath BP; Rangappa KS
    Med Chem; 2007 May; 3(3):269-76. PubMed ID: 17504198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.